Aberdeen Group plc Trims Position in Tenet Healthcare Corporation $THC

Aberdeen Group plc reduced its stake in shares of Tenet Healthcare Corporation (NYSE:THC) by 37.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 37,237 shares of the company’s stock after selling 22,372 shares during the period. Aberdeen Group plc’s holdings in Tenet Healthcare were worth $7,492,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. NewEdge Advisors LLC raised its holdings in shares of Tenet Healthcare by 6.1% during the 1st quarter. NewEdge Advisors LLC now owns 2,890 shares of the company’s stock valued at $389,000 after buying an additional 166 shares during the period. Jones Financial Companies Lllp boosted its holdings in shares of Tenet Healthcare by 299.1% during the first quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock valued at $229,000 after acquiring an additional 1,274 shares during the period. Sivia Capital Partners LLC acquired a new position in Tenet Healthcare during the 2nd quarter worth $290,000. Chicago Partners Investment Group LLC bought a new position in Tenet Healthcare during the second quarter valued at about $273,000. Finally, Stephens Inc. AR bought a new stake in shares of Tenet Healthcare during the 2nd quarter worth $306,000. Institutional investors and hedge funds own 95.44% of the company’s stock.

Wall Street Analyst Weigh In

THC has been the subject of several research reports. Royal Bank Of Canada raised their price target on shares of Tenet Healthcare from $253.00 to $277.00 and gave the stock an “outperform” rating in a report on Thursday, February 12th. KeyCorp boosted their price objective on shares of Tenet Healthcare from $225.00 to $250.00 and gave the stock an “overweight” rating in a report on Thursday, February 12th. TD Cowen reaffirmed a “buy” rating on shares of Tenet Healthcare in a report on Thursday, February 12th. Weiss Ratings raised Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday, December 29th. Finally, UBS Group lifted their price objective on Tenet Healthcare from $260.00 to $288.00 and gave the stock a “buy” rating in a research report on Thursday, February 12th. One research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $247.67.

Tenet Healthcare Stock Up 0.6%

Tenet Healthcare stock opened at $229.56 on Friday. The company has a market cap of $19.96 billion, a P/E ratio of 14.82, a price-to-earnings-growth ratio of 1.12 and a beta of 1.44. Tenet Healthcare Corporation has a 1-year low of $109.82 and a 1-year high of $235.77. The company has a fifty day simple moving average of $201.87 and a 200 day simple moving average of $197.17. The company has a current ratio of 1.76, a quick ratio of 1.68 and a debt-to-equity ratio of 2.18.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.08 by $0.62. The firm had revenue of $5.53 billion for the quarter, compared to analyst estimates of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The company’s quarterly revenue was up 8.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $3.44 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Research analysts anticipate that Tenet Healthcare Corporation will post 12.24 earnings per share for the current fiscal year.

Insider Activity at Tenet Healthcare

In related news, Director Nadja West sold 2,178 shares of the firm’s stock in a transaction dated Monday, December 15th. The shares were sold at an average price of $197.47, for a total transaction of $430,089.66. Following the transaction, the director directly owned 28,480 shares of the company’s stock, valued at approximately $5,623,945.60. This trade represents a 7.10% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.81% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.